Literature DB >> 2212374

The daylong pattern of the antianginal effect of long-term three times daily administered isosorbide dinitrate.

M M Bassan1.   

Abstract

Three times daily administration of isosorbide dinitrate may avoid much of the tolerance seen with more frequent dosing. To determine the daylong pattern of the antianginal effect of three times daily isosorbide dinitrate, eight men with stable exertional angina and a positive exercise test were studied. The subjects had demonstrated increased exercise duration in response to oral isosorbide dinitrate therapy and absence of complete tolerance to long-term three times daily isosorbide dinitrate. Treadmill exercise to onset of angina was performed over 2 days at 8 AM, 9 AM, 11 AM, 1 PM, 2 PM, 4 PM, 6 PM and 7 PM. On one day each patient received isosorbide dinitrate at 8 AM, 1 PM and 6 PM in a previously titrated dose (mean 27.5 mg), which had been taken three times daily for at least 2 weeks. On the other day at the same hours each patient received double blind a placebo identical in appearance to isosorbide dinitrate. One hour after the 8 AM dose of isosorbide dinitrate, mean systolic blood pressure at rest had fallen by 19 mm Hg and mean exercise time to angina increased by 200 s. However, by 11 AM exercise time had returned to control level. One hour after the 1 PM dose of isosorbide dinitrate, exercise time increased by a mean of 150 s but was again at control level 2 h later.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212374     DOI: 10.1016/s0735-1097(10)80344-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

Review 1.  An update on nitrate tolerance: can it be avoided?

Authors:  S R Maxwell; M J Kendall
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

Review 2.  Update on nitrate tolerance.

Authors:  J O Parker
Journal:  Br J Clin Pharmacol       Date:  1992       Impact factor: 4.335

Review 3.  Drug Therapy for Stable Angina Pectoris.

Authors:  Talla A Rousan; Sunil T Mathew; Udho Thadani
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

4.  Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP.

Authors:  G A Soff; T L Cornwell; D L Cundiff; S Gately; T M Lincoln
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

Review 5.  Nitrate tolerance in angina therapy. How to avoid it.

Authors:  J D Rutherford
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

Review 6.  Short and long-acting oral nitrates for stable angina pectoris.

Authors:  U Thadani; R J Lipicky
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

7.  Anti-ischemic effects of first and second dose of 20 mg isosorbide dinitrate administered 5 hours apart: attenuation of effects despite rising plasma concentration.

Authors:  G Lehmann; G Reiniger; H Wolf; A Beyerle; W Rudolph
Journal:  Cardiovasc Drugs Ther       Date:  1995-04       Impact factor: 3.727

Review 8.  Vasodilator Therapy: Nitrates and Nicorandil.

Authors:  Jason M Tarkin; Juan Carlos Kaski
Journal:  Cardiovasc Drugs Ther       Date:  2016-08       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.